These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4436937)

  • 21. Effect of catecholamines on plasma growth hormone in dogs.
    Takahashi K; Tsushima T; Irie M
    Endocrinol Jpn; 1973 Jun; 20(3):323-30. PubMed ID: 4148688
    [No Abstract]   [Full Text] [Related]  

  • 22. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 23. [A comprehensive method of determining catecholamines, DOPA and 5-hydroxyindoleacetic acid in urine].
    Nikiragina GP; Khoreva SA
    Lab Delo; 1988; (9):8-11. PubMed ID: 2461495
    [No Abstract]   [Full Text] [Related]  

  • 24. [Administration of the catecholamine precursor, L-DOPA, for evaluating their in vivo biosynthesis in hypertension].
    Kiseleva ZM; Parfenova EV; Erina EV; Shkhvatsabaia IK
    Kardiologiia; 1979 Oct; 19(10):55-60. PubMed ID: 502171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The 3d catecholamine--dopamine].
    Sotskova TV
    Klin Med (Mosk); 1970 Apr; 48(4):117-20. PubMed ID: 4915309
    [No Abstract]   [Full Text] [Related]  

  • 26. Concentration of dopamine in plasma, activity of dopamine beta-hydroxylase in serum and urinary excretion of free catecholamines and vanillylmandelic acid in women chronically exposed to carbon disulphide.
    Stanosz S; Kuligowski D; Pieleszek A; Zuk E; Rzechuła D; Chlubek D
    Int J Occup Med Environ Health; 1994; 7(3):257-61. PubMed ID: 7842240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fluorometric trihydroxyindolic method for determining catecholamines and 3,4-dihydroxyphenylalanine in urine].
    Pozdeev VK
    Biull Eksp Biol Med; 1980 May; 89(5):628-30. PubMed ID: 6772258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases].
    Vasil'ev VN; Matlina ESh
    Vopr Med Khim; 1977; (3):332-8. PubMed ID: 888397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a peripheral effect of fusaric acid, a dopamine beta-hydroxylase inhibitor, on serotonin metabolism.
    Bonnay MM; Guerinot F; Bohuon CJ
    Biochem Pharmacol; 1974 Oct; 23(19):2770-3. PubMed ID: 4419680
    [No Abstract]   [Full Text] [Related]  

  • 31. Excretion of catecholamines and tryptophan derivatives in schizophrenia.
    Mileikovskii YA
    Neurosci Behav Physiol; 1979; 9(4):325-8. PubMed ID: 158714
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biogenic amines in chronic pancreatitis].
    Geller LI; Kazimirchik AP; Amatniak AG; Kontsevaia NG
    Vopr Med Khim; 1973; 19(6):570-3. PubMed ID: 4212567
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of the sympathico-adrenal system in the pathogenesis of hypertensive disease].
    Shvatsabaia IK; Kiseleva ZM
    Kardiologiia; 1974 Aug; 14(8):42-6. PubMed ID: 4431161
    [No Abstract]   [Full Text] [Related]  

  • 34. [The state of the sympathetico-adrenal system in the development of hypertension].
    Speranskiĭ MD
    Kardiologiia; 1967 Mar; 7(3):24-6. PubMed ID: 5604604
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the determination of adrenaline, noradrenaline, dopamine and dopa in a single urine sample].
    Matlina ESh; Kiseleva ZM
    Probl Endokrinol Gormonoter; 1966; 12(2):111-6. PubMed ID: 6004103
    [No Abstract]   [Full Text] [Related]  

  • 36. [The relationship of the metabolism of biogenic amines to affective pathology in chronic alcoholism].
    Skugarevskaia EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):896-9. PubMed ID: 5364242
    [No Abstract]   [Full Text] [Related]  

  • 37. [Some characteristics of the state of the sympatho-adrenal system in various hemodynamic variants of hypertension].
    Sumarokov AV; Bol'shakova TD; Lukicheva TI; Eristavi NL; Mikhaĭlov AA
    Kardiologiia; 1975 May; 15(5):28-32. PubMed ID: 239270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of dopamine-beta-hydroxylase inhibitors on thermoregulation in reserpine-treated rats.
    Ishii Y; Yoshikawa A; Homma M
    Neuropharmacology; 1976 Jun; 15(6):359-62. PubMed ID: 180451
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies of catecholamine metabolism in two hereditary forms of dystonia.
    Wotten GF; Eldridge R; Gordon EK; Axelrod J
    Trans Am Neurol Assoc; 1973; 98():245-7. PubMed ID: 4784942
    [No Abstract]   [Full Text] [Related]  

  • 40. Simultaneous measurement of urinary and plasma norepinephrine, epinephrine, dopamine, dihydroxyphenylalanine, and dihydroxyphenylacetic acid by coupled-column high-performance liquid chromatography on C8 and C18 stationary phases.
    Benedict CR
    J Chromatogr; 1987 Jan; 385():369-75. PubMed ID: 3104375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.